Targeting hypoxia inducible factor (HIF)-2 with AB521, a novel and potent small molecule HIF-2 inhibitor, for the treatment of clear cell renal cell carcinoma
Dana Piovesan,Soonweng Cho,Kenneth V. Lawson,Kai H. Liao,Paul G. Foster,Tzuling Cheng,Matthew J. Walters,Kelsey E. Sivick Gauthier
